CELL THERAPEUTICS INC
CELL THERAPEUTICS INC (CTIC) is a publicly traded company in the Unknown sector. Across all available filings, 34 corporate insiders have executed 1000 transactions totaling $105.7M, demonstrating a bearish sentiment with -$55.2M in net insider flow. The most recent transaction on Oct 2, 2023 involved a purchase of 2.16 shares valued at $75.
CTIC Insider Activity Summary
Who Is Buying CTIC Stock?
No significant insider buying has been recorded for CTIC in the recent period.
Who Is Selling CTIC Stock?
No significant insider selling has been recorded for CTIC in the recent period.
Is CELL THERAPEUTICS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CTIC is bearish with an Insider Alignment Score of 24/100 and a net flow of -$55.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CTIC Frequently Asked Questions
Understanding CTIC Insider Activity
Insider trading at CELL THERAPEUTICS INC (CTIC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 34 insiders are actively trading CTIC stock, having executed 1000 transactions in the past 90 days. The most active insider is Value Fund L. P. Biotechnology (Executive), who has made 9 transactions totaling $80.6M.
Related Tools
Track CELL THERAPEUTICS INC Insider Activity
Get notified when executives and directors at CTIC file new Form 4 transactions